Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Cavallo

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer|December 15, 1988
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphaticallyG Cortesina, A De Stefani, M Giovarelli, et al.
Head & Neck|March 1, 1991
Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancerG Cortesina, A De Stefani, E Galeazzi, et al.
British Journal of Cancer|March 1, 1994
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphaticallyG Cortesina, A De Stefani, E Galeazzi, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|May 31, 1980
Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomasG P Cavallo, F Beatrice, E Poggio, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|September 1, 1989
[Perilymphatic injection of interleukin-2 (IL-2) in recurrent squamous cell carcinoma of the head and neck]G Cortesina, A De Stefani, M Giovarelli, et al.
Tumori|February 28, 1982
Production of leukocyte migration inhibition factor by lymphocytes of larynx cancer patients stimulated by laryngeal carcinoma solubilized membrane antigensG Cortesina, G P Cavallo, F Beatrice, et al.
Minerva Medica|April 28, 1982
[Immunologic monitoring in patients with laryngeal cancer. Critical considerations on the current possibilities of clinical application]P Menzio, G Cortesina, A Sartoris, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|January 1, 1982
Evidence of suppressor activity mediated by concanavalin-A stimulated cells towards aspecific LIF productionF Beatrice, E Poggio, B Morra, et al.
The Laryngoscope|June 1, 1984
Evaluation of blocking mechanisms against immunological responses in patients with laryngeal carcinomaB Morra, F Beatrice, G P Cavallo, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 1, 1985
[Evaluation of the immune response in patients with laryngeal cancer using specific and nonspecific tests: initial results of a follow-up in 80 cases]G Cortesina, G P Cavallo, M Bussi, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer|December 15, 1988
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphaticallyG Cortesina, A De Stefani, M Giovarelli, et al.
Head & Neck|March 1, 1991
Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancerG Cortesina, A De Stefani, E Galeazzi, et al.
British Journal of Cancer|March 1, 1994
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphaticallyG Cortesina, A De Stefani, E Galeazzi, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|May 31, 1980
Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomasG P Cavallo, F Beatrice, E Poggio, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|September 1, 1989
[Perilymphatic injection of interleukin-2 (IL-2) in recurrent squamous cell carcinoma of the head and neck]G Cortesina, A De Stefani, M Giovarelli, et al.
Tumori|February 28, 1982
Production of leukocyte migration inhibition factor by lymphocytes of larynx cancer patients stimulated by laryngeal carcinoma solubilized membrane antigensG Cortesina, G P Cavallo, F Beatrice, et al.
Minerva Medica|April 28, 1982
[Immunologic monitoring in patients with laryngeal cancer. Critical considerations on the current possibilities of clinical application]P Menzio, G Cortesina, A Sartoris, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|January 1, 1982
Evidence of suppressor activity mediated by concanavalin-A stimulated cells towards aspecific LIF productionF Beatrice, E Poggio, B Morra, et al.
The Laryngoscope|June 1, 1984
Evaluation of blocking mechanisms against immunological responses in patients with laryngeal carcinomaB Morra, F Beatrice, G P Cavallo, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 1, 1985
[Evaluation of the immune response in patients with laryngeal cancer using specific and nonspecific tests: initial results of a follow-up in 80 cases]G Cortesina, G P Cavallo, M Bussi, et al.
Pageof 5